UB Paderborn / Katalog / Suche / in CDI

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

The lancet oncology, 2017-08, Vol.18 (8), p.1116-1125

2017

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer

The New England journal of medicine, 2007-08, Vol.357 (7), p.664-672

2007

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms—Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups

Journal of clinical oncology, 2009-01, Vol.27 (1), p.78-84

2009

Link zum Volltext

Verfügbarkeit prüfen

Quality of life comparing carboplatin with cisplatin in the treatment of non–small cell lung cancer

European journal of cancer (1990), 2018-03, Vol.91, p.167-167

Snee, Michael

2018

Link zum Volltext

Verfügbarkeit prüfen

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

The Lancet (British edition), 2008-05, Vol.371 (9625), p.1685-1694

2008

Link zum Volltext

Verfügbarkeit prüfen

Traditional Phase 1 and 2 Studies in Thoracic Radiation Oncology Should Be Abandoned

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (3), p.487-489

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative

BMJ open, 2021-09, Vol.11 (9), p.e046396-e046396

2021

Link zum Volltext

Verfügbarkeit prüfen

Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis

Journal of clinical oncology, 2006-08, Vol.24 (24), p.3823-3830

2006

Link zum Volltext

Verfügbarkeit prüfen

The Mesothelioma and Radical Surgery Randomized Controlled Trial: The MARS Feasibility Study

Journal of thoracic oncology, 2009-10, Vol.4 (10), p.1254-1258

2009

Link zum Volltext

Verfügbarkeit prüfen

Guidelines on the radical management of patients with lung cancer

Thorax, 2010-10, Vol.65 (Suppl 3), p.iii1-iii27

2010

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013–2017: A nationwide CAS registry analysis from the I-O Optimise initiative

Lung cancer (Amsterdam, Netherlands), 2021-12, Vol.162, p.185-193

2021

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial

Journal of clinical oncology, 2019-05, Vol.37 (14), p.1200-1208

2019

Link zum Volltext

Verfügbarkeit prüfen

18F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial

Journal of thoracic oncology, 2019-07, Vol.14 (7), p.1296-1305

2019

Link zum Volltext

Verfügbarkeit prüfen

Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis

The European respiratory journal, 2019-06, Vol.53 (6), p.1801568

2019

Link zum Volltext

Verfügbarkeit prüfen

P1.05-030 Lung SABR for Early Stage Lung Cancer: Outcomes and Toxicity of 803 Patients Treated at the Leeds Cancer Centre: Topic: SBRT

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S632-S632

2017

Link zum Volltext

Verfügbarkeit prüfen

P1.05-030 Lung SABR for Early Stage Lung Cancer: Outcomes and Toxicity of 803 Patients Treated at the Leeds Cancer Centre

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S632

2017

Link zum Volltext

Verfügbarkeit prüfen

Heparin prophylaxis has no benefit in medical patients

BMJ (Online), 2012-07, Vol.345, p.e4940

Snee, Michael

2012

Link zum Volltext

Verfügbarkeit prüfen

Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity

British journal of radiology, 2016-01, Vol.89 (1058), p.20150628

2016

Link zum Volltext

Verfügbarkeit prüfen

Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative

BMJ open, 2021-05, Vol.11 (5), p.e043442-e043442

2021

Link zum Volltext

Verfügbarkeit prüfen

Occult Nodal Disease in Patients With Non–Small-Cell Lung Cancer Who are Suitable for Stereotactic Ablative Body Radiation

Clinical lung cancer, 2014-11, Vol.15 (6), p.466-469

2014

Link zum Volltext

Verfügbarkeit prüfen

P1.05-029 SABRTOOTH-A Feasibility Study of SABR Compared to Surgery in Patients with Peripheral Stage I NSCLC Considered to Be at Higher Risk from Surgery

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S631-S632

2017

Link zum Volltext

Verfügbarkeit prüfen

P1.05-029 SABRTOOTH-A Feasibility Study of SABR Compared to Surgery in Patients with Peripheral Stage I NSCLC Considered to Be at Higher Risk from Surgery: Topic: SBRT

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S631-S632

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer

Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms—Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups

Quality of life comparing carboplatin with cisplatin in the treatment of non–small cell lung cancer

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

Traditional Phase 1 and 2 Studies in Thoracic Radiation Oncology Should Be Abandoned

Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative

Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis

The Mesothelioma and Radical Surgery Randomized Controlled Trial: The MARS Feasibility Study

Guidelines on the radical management of patients with lung cancer

Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013–2017: A nationwide CAS registry analysis from the I-O Optimise initiative

Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial

SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection

18F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial

Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis

P1.05-030 Lung SABR for Early Stage Lung Cancer: Outcomes and Toxicity of 803 Patients Treated at the Leeds Cancer Centre: Topic: SBRT

P1.05-030 Lung SABR for Early Stage Lung Cancer: Outcomes and Toxicity of 803 Patients Treated at the Leeds Cancer Centre

Heparin prophylaxis has no benefit in medical patients

Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity

Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative

Occult Nodal Disease in Patients With Non–Small-Cell Lung Cancer Who are Suitable for Stereotactic Ablative Body Radiation

P1.05-029 SABRTOOTH-A Feasibility Study of SABR Compared to Surgery in Patients with Peripheral Stage I NSCLC Considered to Be at Higher Risk from Surgery

P1.05-029 SABRTOOTH-A Feasibility Study of SABR Compared to Surgery in Patients with Peripheral Stage I NSCLC Considered to Be at Higher Risk from Surgery: Topic: SBRT

CONVERT: An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS)

Suchergebnisse filtern